JPH04335886A - New enzyme, production thereof and production of optically active (r)-2-hydroxy-4-phenylbutyric acid - Google Patents

New enzyme, production thereof and production of optically active (r)-2-hydroxy-4-phenylbutyric acid

Info

Publication number
JPH04335886A
JPH04335886A JP3131964A JP13196491A JPH04335886A JP H04335886 A JPH04335886 A JP H04335886A JP 3131964 A JP3131964 A JP 3131964A JP 13196491 A JP13196491 A JP 13196491A JP H04335886 A JPH04335886 A JP H04335886A
Authority
JP
Japan
Prior art keywords
phenylbutyric acid
oxo
enzyme
acid
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3131964A
Other languages
Japanese (ja)
Other versions
JP2750017B2 (en
Inventor
Kenji Soda
健次 左右田
Nobuyoshi Nakajima
中島 伸佳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Original Assignee
Daicel Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daicel Chemical Industries Ltd filed Critical Daicel Chemical Industries Ltd
Priority to JP3131964A priority Critical patent/JP2750017B2/en
Publication of JPH04335886A publication Critical patent/JPH04335886A/en
Application granted granted Critical
Publication of JP2750017B2 publication Critical patent/JP2750017B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To efficiently produce the subject optically active (R)-2-hydroxy-4- phenylbutyric acid from 2-oxo-4-phenylbutyric acid. CONSTITUTION:An enzyme obtained by extraction and purification from a microorganism belonging to Leuconostic genus is allowed to act on 2-oxo-4- phenylbutyric acid on the presence of reduced type nicotinamde adenine dinucleotide phosphate NADPH as a coenzyme to asymmetrically reduce it. The above-mentioned enzyme has following physicochemical properties; Optimum pH: about 6.0, Stable pH region: 6-7, Optimum temperature: about 45 deg.C. Thermal stability: <=40 deg.C, Michaelis constant value Km for 2-oxo-4-phenylbutyric acid: 0.29mM, Molecular weight: 46000 and Inhibitor: mercury chloride and mercury para-chlorobenzoate.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、新規な酵素およびその
製造方法、並びに前記酵素を用いる光学活性な(R)−
2−ヒドロキシ−4−フェニル酪酸の製造方法に関する
[Field of Industrial Application] The present invention relates to a novel enzyme, a method for producing the same, and an optically active (R)-
The present invention relates to a method for producing 2-hydroxy-4-phenylbutyric acid.

【0002】0002

【従来の技術および発明が解決しようとする課題】近年
、酵素的不斉還元反応を利用して、光学活性体を得る方
法が検討されている。例えば、特公昭61−11591
号公報、特公平1−27717号公報、特開昭62−2
86号公報および特開昭63−32480号公報には、
乳酸菌が生産する数種の脱水素酵素が報告されている。 これらの脱水素酵素は、還元型ニコチンアミド・アデニ
ン・ジヌクレオチド(以下、NADHという)を補酵素
として、各種の2−オキソカルボン酸を不斉的に還元し
、対応する光学活性な2−ヒドロキシカルボン酸を生成
する。
[Prior Art and Problems to be Solved by the Invention] In recent years, methods for obtaining optically active substances using enzymatic asymmetric reduction reactions have been studied. For example, Tokuko Sho 61-11591
Publication No. 1-27717, Japanese Unexamined Patent Publication No. 1986-2
No. 86 and Japanese Unexamined Patent Publication No. 63-32480,
Several types of dehydrogenases produced by lactic acid bacteria have been reported. These dehydrogenases asymmetrically reduce various 2-oxocarboxylic acids using reduced nicotinamide adenine dinucleotide (hereinafter referred to as NADH) as a coenzyme to produce the corresponding optically active 2-hydroxy Produces carboxylic acid.

【0003】また、特開昭63−304979号公報に
は、還元型ニコチンアミド・アデニン・ジヌクレオチド
・リン酸(以下、NADPHという)を補酵素とし、γ
−置換アセト酢酸エステルから(R)−γ−置換−β−
ヒドロキシ酪酸エステルを生成する酵素として、スポロ
ボロマイセス(Sporobolomyces)属に属
する菌株から抽出した還元酵素が開示されている。
Furthermore, Japanese Patent Application Laid-open No. 63-304979 discloses that reduced nicotinamide adenine dinucleotide phosphate (hereinafter referred to as NADPH) is used as a coenzyme, and γ
-Substituted acetoacetate to (R)-γ-substituted-β-
As an enzyme that produces hydroxybutyric acid ester, a reductase extracted from a strain belonging to the genus Sporobolomyces has been disclosed.

【0004】一方、光学活性な(R)−2−ヒドロキシ
−4−フェニル酪酸は、医薬品などの合成中間体として
有用な化合物である。しかしながら、前記酵素に関して
、2−オキソ−4−フェニル酪酸を不斉還元し、(R)
−2−ヒドロキシ−4−フェニル酪酸を生成する活性は
知られていない。
On the other hand, optically active (R)-2-hydroxy-4-phenylbutyric acid is a compound useful as a synthetic intermediate for pharmaceuticals and the like. However, regarding the enzyme, 2-oxo-4-phenylbutyric acid is asymmetrically reduced and (R)
The activity of producing -2-hydroxy-4-phenylbutyric acid is not known.

【0005】従って、本発明の目的は、2−オキソ−4
−フェニル酪酸を選択的に不斉還元し、光学活性な(R
)−2−ヒドロキシ−4−フェニル酪酸を効率よく生成
する新規酵素とその製造方法を提供することにある。
[0005] Therefore, the object of the present invention is to obtain 2-oxo-4
- selectively asymmetrically reduces phenylbutyric acid to produce optically active (R
)-2-Hydroxy-4-phenylbutyric acid efficiently and a method for producing the same.

【0006】本発明の他の目的は、酵素の作用により、
2−オキソ−4−フェニル酪酸から光学活性な(R)−
2−ヒドロキシ−4−フェニル酪酸を効率よく得ること
ができる製造方法を提供することにある。
[0006] Another object of the present invention is to
Optically active (R)- from 2-oxo-4-phenylbutyric acid
An object of the present invention is to provide a production method that can efficiently obtain 2-hydroxy-4-phenylbutyric acid.

【0007】[0007]

【発明の構成】本発明者らは、2−オキソ−4−フェニ
ル酪酸を不斉還元し、(R)−2−ヒドロキシ−4−フ
ェニル酪酸を生成しうる酵素を探索した結果、ロイコノ
ストック(Leuconostoc)属に属する微生物
が、前記目的を達成しうる酵素を生産することを見いだ
すと共に、この酵素の理化学的性質を明らかにすること
により、本発明を完成した。
[Structure of the Invention] As a result of searching for an enzyme capable of asymmetrically reducing 2-oxo-4-phenylbutyric acid to produce (R)-2-hydroxy-4-phenylbutyric acid, the present inventors discovered that leuconostoc The present invention was completed by discovering that microorganisms belonging to the genus Leuconostoc produce an enzyme capable of achieving the above object, and by clarifying the physicochemical properties of this enzyme.

【0008】すなわち、本発明は、下記(1) 〜(8
) に示す理化学的性質を有する新規酵素を提供する。
That is, the present invention provides the following (1) to (8)
) A novel enzyme having the following physicochemical properties is provided.

【0009】(1) 作用および基質特異性:NADP
Hの存在下、2−オキソ−4−フェニル酪酸を不斉還元
し、(R)−2−ヒドロキシ−4−フェニル酪酸を生成
する(2) 至適pH:6.0付近(リン酸緩衝液)(
3) 安定pH範囲:6〜7(リン酸緩衝液)(4) 
至適温度:45℃付近(pH6.0)(5) 熱安定性
:40℃以下で安定(pH7.2、処理時間20分) (6) 2−オキソ−4−フェニル酪酸に対するミハエ
リス定数Km値:0.29mM (7) 分子量:46000(ゲル濾過法)(8) 阻
害剤:塩化水銀およびパラクロロ水銀安息香酸また、本
発明は、ロイコノストック(Leuconostoc)
属に属する微生物を培養し、該培養物から、前記理化学
的性質を有する酵素を採取する新規酵素の製造方法を提
供する。
(1) Action and substrate specificity: NADP
In the presence of H, 2-oxo-4-phenylbutyric acid is asymmetrically reduced to produce (R)-2-hydroxy-4-phenylbutyric acid (2) Optimum pH: around 6.0 (phosphate buffer )(
3) Stable pH range: 6-7 (phosphate buffer) (4)
Optimal temperature: Around 45°C (pH 6.0) (5) Thermal stability: Stable below 40°C (pH 7.2, treatment time 20 minutes) (6) Michaelis constant Km value for 2-oxo-4-phenylbutyric acid : 0.29mM (7) Molecular weight: 46,000 (gel filtration method) (8) Inhibitor: mercuric chloride and parachloromercuric benzoic acid The present invention also uses Leuconostoc.
The present invention provides a method for producing a novel enzyme, which involves culturing a microorganism belonging to the genus and collecting an enzyme having the above-mentioned physicochemical properties from the culture.

【0010】さらに、本発明は、NADPHの存在下、
前記酵素を、2−オキソ−4−フェニル酪酸に作用させ
て不斉還元する、光学活性な(R)−2−ヒドロキシ−
4−フェニル酪酸の製造方法をも提供する。
[0010]Furthermore, the present invention provides that in the presence of NADPH,
The optically active (R)-2-hydroxy- which causes the enzyme to act on 2-oxo-4-phenylbutyric acid to asymmetrically reduce it.
Also provided is a method for producing 4-phenylbutyric acid.

【0011】本発明の新規酵素の起源は、特に限定され
るものではなく、前記理化学的性質を有する酵素を生産
しうる微生物であればよい。好ましい微生物は、例えば
乳酸菌、特にロイコノストック(Leuconosto
c)属に属する微生物である。これらの微生物の中で好
ましい菌株は、ロイコノストック・デキストラニカム(
Leuconostocdextranicum)AT
CC27310である。
The origin of the novel enzyme of the present invention is not particularly limited, and any microorganism that can produce an enzyme having the above-mentioned physicochemical properties may be used. Preferred microorganisms are, for example, lactic acid bacteria, especially Leuconostoc.
c) It is a microorganism belonging to the genus. Among these microorganisms, the preferred strain is Leuconostoc dextranicum (
Leuconostocdextranicum)AT
It is CC27310.

【0012】前記ATCC番号が付された微生物は、ア
メリカン  タイプ  カルチャー  コレクション(
American Type Culture Col
lection、ATCC)発行の「Catalogu
e of Bacteria Phages rDNA
 Vectors,第16版(1985)」に記載され
ており、該ATCCから入手できる。
[0012] The microorganisms assigned the ATCC numbers are listed in the American Type Culture Collection (
American Type Culture Col.
Catalog published by ATCC)
e of Bacteria Phages rDNA
Vectors, 16th Edition (1985), available from the ATCC.

【0013】さらに、これらの微生物は、前記理化学的
性質を有する酵素を生産する限り、野生株、変異株、又
は細胞融合もしくは遺伝子操作法などの遺伝的手法によ
り誘導される組み換え株などのいずれの菌株でも好適に
用いることができる。
Furthermore, these microorganisms may be wild strains, mutant strains, or recombinant strains induced by genetic methods such as cell fusion or genetic manipulation methods, as long as they produce enzymes having the above-mentioned physicochemical properties. Bacterial strains can also be suitably used.

【0014】なお、酵素の理化学的性質は、測定上不可
避的な誤差を含んでいる。従って、例示すれば、本発明
の酵素には、下記の理化学的性質を有する酵素も含まれ
る。
[0014] The physicochemical properties of enzymes include unavoidable errors in measurement. Therefore, by way of example, the enzymes of the present invention also include enzymes having the following physicochemical properties.

【0015】(2) 至適pH:5.5〜6.5程度、
(3) 安定なpH範囲:5.5〜7.5程度、(4)
 至適温度:40〜50℃程度、(6) 2−オキソ−
4−フェニル酪酸に対するミハエリス定数Km値:0.
2〜0.5mM程度 (7) 分子量:40000〜50000程度前記酵素
は、前記(1) 〜(8) の理化学的性質に加えて、
(9) NADPHの存在下、アセトアルデヒド、n−
ブチルアルデヒドなどのアルデヒド類、2−オキソヘキ
サン酸、2−オキソオクタン酸などのケトン類を還元し
、これらに対応する等モルのアルコールを生成する作用
を有するのが好ましい。
(2) Optimum pH: about 5.5 to 6.5,
(3) Stable pH range: about 5.5 to 7.5, (4)
Optimal temperature: about 40 to 50°C, (6) 2-oxo-
Michaelis constant Km value for 4-phenylbutyric acid: 0.
Approximately 2 to 0.5mM (7) Molecular weight: approximately 40,000 to 50,000 The enzyme has the following physical and chemical properties as described in (1) to (8) above.
(9) In the presence of NADPH, acetaldehyde, n-
It is preferable to have the function of reducing aldehydes such as butyraldehyde, ketones such as 2-oxohexanoic acid and 2-oxooctanoic acid, and producing equimolar alcohols corresponding to these.

【0016】前記酵素は、NADHではなく、補酵素と
してのNADPHの存在下、2−オキソ−4−フェニル
酪酸を選択的に不斉還元する。
[0016] The enzyme selectively asymmetrically reduces 2-oxo-4-phenylbutyric acid in the presence of NADPH as a coenzyme rather than NADH.

【0017】本発明の酵素は、前記微生物を培地で培養
し、培養菌体から抽出精製することにより得ることがで
きる。
The enzyme of the present invention can be obtained by culturing the above-mentioned microorganism in a medium and extracting and purifying the cultured cells.

【0018】培地は、微生物が増殖し得るものであれば
特に制限されない。培地の炭素源としては、上記微生物
が利用可能であればいずれも使用でき、例えば、グルコ
ース、フルクトース、シュクロース、デキストリン、デ
ンプンなどの糖類;ソルビトール、エタノール、グリセ
ロールなどのアルコール類;フマル酸、クエン酸、酢酸
、プロピオン酸などの有機酸類及びその塩類;パラフィ
ンなどの炭化水素類;これらの混合物などが使用できる
。窒素源としては、例えば、塩化アンモニウム、硫酸ア
ンモニウム、リン酸アンモニウムなどの無機酸のアンモ
ニウム塩;フマル酸アンモニウム、クエン酸アンモニウ
ムなどの有機酸のアンモニウム塩;肉エキス、酵母エキ
ス、麦芽エキス、ペプトン、コーンスティープリカー、
カゼイン加水分解物、尿素などの無機又は有機含窒素化
合物;これらの混合物を使用できる。また、培地には、
前記成分以外に、通常の培養に用いられる栄養源、例え
ば、無機塩、微量金属塩、ビタミン類などを適宜、混合
して用いることができる。さらに、必要に応じて、微生
物の増殖を促進する因子、培地のpH保持に有効な物質
、本発明の目的化合物の生成能力を高める因子、例えば
、2−オキソ−4−フェニル酪酸なども添加できる。
[0018] The medium is not particularly limited as long as it allows microorganisms to grow. As a carbon source for the culture medium, any of the above-mentioned microorganisms can be used as long as they can be used; for example, sugars such as glucose, fructose, sucrose, dextrin, and starch; alcohols such as sorbitol, ethanol, and glycerol; fumaric acid, and citric acid. Organic acids such as acids, acetic acid and propionic acid and their salts; hydrocarbons such as paraffin; mixtures thereof, and the like can be used. Nitrogen sources include, for example, ammonium salts of inorganic acids such as ammonium chloride, ammonium sulfate, ammonium phosphate; ammonium salts of organic acids such as ammonium fumarate, ammonium citrate; meat extract, yeast extract, malt extract, peptone, corn. steep liquor,
Inorganic or organic nitrogen-containing compounds such as casein hydrolyzate and urea; mixtures thereof can be used. In addition, the culture medium has
In addition to the above-mentioned components, nutrient sources used in normal culture, such as inorganic salts, trace metal salts, vitamins, etc., can be appropriately mixed and used. Furthermore, if necessary, factors that promote the growth of microorganisms, substances that are effective in maintaining the pH of the culture medium, and factors that increase the ability to produce the target compound of the present invention, such as 2-oxo-4-phenylbutyric acid, can also be added. .

【0019】微生物の培養は、生育に適した条件下、例
えば、培地のpH3.0〜9.5、好ましくは4〜8、
培養温度20〜45℃、好ましくは25〜37℃の条件
で行なうことができる。微生物の培養は、嫌気的又は好
気的条件下で行なうことができる。培養時間は、例えば
、5〜120時間、好ましくは12〜72時間程度であ
る。
[0019] The microorganisms are cultured under conditions suitable for growth, for example, the pH of the medium is 3.0 to 9.5, preferably 4 to 8;
The cultivation can be carried out at a culture temperature of 20 to 45°C, preferably 25 to 37°C. Cultivation of microorganisms can be carried out under anaerobic or aerobic conditions. The culture time is, for example, about 5 to 120 hours, preferably about 12 to 72 hours.

【0020】本発明の酵素は、培養した微生物菌体から
抽出し精製することにより得ることができる。例えば、
培養物を遠心分離に供して菌体を回収し、超音波破砕や
、機械的破砕法と遠心分離法とを組合わせる方法などに
より無細胞抽出液を得る。次いで、抽出液を、例えば、
ストレプトマイシン硫酸処理、硫酸アンモニウム分画、
イオン交換クロマトグラフィー、アフィニティークロマ
トグラフィー、溶出液による溶出、ゲル濾過法、限外濾
過法などの通常の精製方法を一種又は二種以上組合せて
精製することにより、酵素を得ることができる。
The enzyme of the present invention can be obtained by extraction and purification from cultured microbial cells. for example,
The culture is subjected to centrifugation to recover bacterial cells, and a cell-free extract is obtained by ultrasonic disruption or a combination of mechanical disruption and centrifugation. Next, the extract is, for example,
Streptomycin sulfate treatment, ammonium sulfate fractionation,
Enzymes can be obtained by purification using one or a combination of two or more conventional purification methods such as ion exchange chromatography, affinity chromatography, elution with an eluate, gel filtration, and ultrafiltration.

【0021】以下に、2−オキソ−4−フェニル酪酸か
ら光学活性な(R)−2−ヒドロキシ−4−フェニル酪
酸を製造する方法について説明する。
A method for producing optically active (R)-2-hydroxy-4-phenylbutyric acid from 2-oxo-4-phenylbutyric acid will be explained below.

【0022】本発明の方法において、前記理化学的性質
を有する酵素により、基質である2−オキソ−4−フェ
ニル酪酸を不斉還元し、(R)−2−ヒドロキシ−4−
フェニル酪酸を生成させるためには、基質と共に補酵素
NADPHが必要である。
In the method of the present invention, the substrate 2-oxo-4-phenylbutyric acid is asymmetrically reduced by the enzyme having the above-mentioned physicochemical properties to form (R)-2-hydroxy-4-
In order to generate phenylbutyric acid, a substrate and a coenzyme NADPH are required.

【0023】不斉還元反応は、前記酵素の活性が安定に
発現する条件下、基質、酵素、NADPHを適当な比率
で混合して反応すればよい。反応系のpHは、例えば、
5〜9、好ましくは6〜8程度である。また、反応温度
は、例えば、10〜60℃、好ましくは20〜40℃程
度である。反応は、撹拌下又は静置下、1〜120時間
程度行うことができる。
[0023] The asymmetric reduction reaction may be carried out by mixing the substrate, enzyme, and NADPH in an appropriate ratio under conditions in which the activity of the enzyme is stably expressed. The pH of the reaction system is, for example,
It is about 5 to 9, preferably about 6 to 8. Further, the reaction temperature is, for example, about 10 to 60°C, preferably about 20 to 40°C. The reaction can be carried out for about 1 to 120 hours under stirring or standing still.

【0024】基質の濃度は、目的とする光学活性体の生
成量および光学純度が低下しない限り特に制限されない
が、例えば、0.1〜10重量%程度が好ましい。また
、基質と、酵素との比率、補酵素と酵素との比率は、目
的とする光学活性体の生成量および光学純度が低下しな
い範囲で選択できる。
The concentration of the substrate is not particularly limited as long as the production amount and optical purity of the desired optically active substance are not reduced, but it is preferably about 0.1 to 10% by weight, for example. Further, the ratio of the substrate to the enzyme and the ratio of the coenzyme to the enzyme can be selected within a range that does not reduce the production amount and optical purity of the desired optically active substance.

【0025】また、反応に際して、補酵素を反応系にリ
サイクルするリサイクル系を構築することにより、(R
)−2−ヒドロキシ−4−フェニル酪酸をさらに効率的
に製造できる。補酵素のリサイクル系は、反応液から補
助酵素を分離する分離手段、リサイクルラインなどを組
合せる慣用の方法により構築できる。
Furthermore, by constructing a recycling system that recycles the coenzyme into the reaction system during the reaction, (R
)-2-hydroxy-4-phenylbutyric acid can be produced more efficiently. A coenzyme recycling system can be constructed by a conventional method that combines a separation means for separating the coenzyme from the reaction solution, a recycling line, and the like.

【0026】さらに、本発明の酵素は、慣用の方法、例
えば、吸着、包括、共有結合、イオン結合、架橋結合な
どの方法により、種々の固定化担体に固定化することに
より固定化酵素として使用することも可能である。担体
の種類は特に制限されず、例えばポリアクリルアミド、
セルロース系材料、スチレン系ポリマー、DEAE−セ
ファデックス、イオン交換樹脂、コラーゲン、アルブミ
ン、カラギーナン、アルギン酸、寒天などであってもよ
い。
Furthermore, the enzyme of the present invention can be used as an immobilized enzyme by immobilizing it on various immobilization carriers by conventional methods such as adsorption, entrapment, covalent bonding, ionic bonding, cross-linking, etc. It is also possible to do so. The type of carrier is not particularly limited, and examples include polyacrylamide,
It may be cellulosic materials, styrenic polymers, DEAE-Sephadex, ion exchange resins, collagen, albumin, carrageenan, alginic acid, agar, etc.

【0027】生成した光学活性な(R)−2−ヒドロキ
シ−4−フェニル酪酸は、慣用の分離精製手段により回
収できる。例えば、反応液を、膜分離、有機溶媒による
抽出、カラムクロマトグラフィー、イオン交換樹脂によ
る分離、減圧濃縮、再結晶などの通常の精製方法に供す
ることにより、前記光学活性体を容易に得ることができ
る。なお、光学活性(R)−2−ヒドロキシ−4−フェ
ニル酪酸の光学純度は、例えば、光学異性体分離カラム
を用いた高速液体クロマトグラフィー(HPLC)によ
り測定できる。
The optically active (R)-2-hydroxy-4-phenylbutyric acid produced can be recovered by conventional separation and purification means. For example, the optically active substance can be easily obtained by subjecting the reaction solution to a conventional purification method such as membrane separation, extraction with an organic solvent, column chromatography, separation using an ion exchange resin, concentration under reduced pressure, or recrystallization. can. The optical purity of optically active (R)-2-hydroxy-4-phenylbutyric acid can be measured, for example, by high performance liquid chromatography (HPLC) using an optical isomer separation column.

【0028】[0028]

【発明の効果】本発明の新規な酵素は、2−オキソ−4
−フェニル酪酸を選択的に不斉還元し、光学活性な(R
)−2−ヒドロキシ−4−フェニル酪酸を効率よく生成
する。
Effect of the invention: The novel enzyme of the present invention has 2-oxo-4
- selectively asymmetrically reduces phenylbutyric acid to produce optically active (R
)-2-hydroxy-4-phenylbutyric acid is efficiently produced.

【0029】本発明の酵素の製造方法によれば、前記の
如き優れた性質を有する酵素を得ることができる。
According to the method for producing an enzyme of the present invention, an enzyme having the above-mentioned excellent properties can be obtained.

【0030】さらに、本発明の製造方法では、前記酵素
の作用により、2−オキソ−4−フェニル酪酸から光学
活性な(R)−2−ヒドロキシ−4−フェニル酪酸を効
率よく製造できる。
Furthermore, in the production method of the present invention, optically active (R)-2-hydroxy-4-phenylbutyric acid can be efficiently produced from 2-oxo-4-phenylbutyric acid by the action of the enzyme.

【0031】[0031]

【実施例】以下に、実施例に基づいて本発明をより詳細
に説明するが、本発明はこれらの実施例に限定されるも
のではない。
EXAMPLES The present invention will be explained in more detail below based on Examples, but the present invention is not limited to these Examples.

【0032】なお、酵素活性は、次のような標準活性測
定法により測定した。
[0032] The enzyme activity was measured by the following standard activity measurement method.

【0033】10μMの2−オキソ−4−フェニル酪酸
、0.1μMのNADPH、100μMのリン酸カリウ
ム緩衝液(pH6.0)及び適量の酵素液を含む全容1
mlの反応系を構成し、37℃で、340nmにおける
NADPHの吸光度の減少を分光光度計にて追跡し、酵
素活性を求めた。なお、上記条件下で、1分間に、1μ
MのNADPHが酸化される酵素量を、酵素活性1単位
(U)とした。
Total volume 1 containing 10 μM 2-oxo-4-phenylbutyric acid, 0.1 μM NADPH, 100 μM potassium phosphate buffer (pH 6.0) and an appropriate amount of enzyme solution.
A ml reaction system was prepared, and the enzyme activity was determined by monitoring the decrease in the absorbance of NADPH at 340 nm at 37° C. using a spectrophotometer. In addition, under the above conditions, 1μ per minute
The amount of enzyme that oxidized NADPH of M was defined as 1 unit (U) of enzyme activity.

【0034】また、比活性は、蛋白質1mg当たりの単
位(U)数として算出した。なお、蛋白量は、牛血清ア
ルブミンを標準物質として用い、ローリイ(Lowry
 )法により測定した。
Further, the specific activity was calculated as the number of units (U) per mg of protein. In addition, the protein amount was determined using bovine serum albumin as a standard substance.
) method.

【0035】実施例1(酵素の精製) グルコース8%、酵母エキス1%、硫酸マンガン10p
pm、炭酸カルシウム2%より成る組成の培地18Lを
30L容のジャーファーメンターに入れ、加熱殺菌した
後、前記と同様な培地で予め培養したロイコノストック
・デキストラニカムIFO27310の培養液500m
lを植菌した。30℃で、200rpm、気相通気の条
件下、18時間培養した。
Example 1 (purification of enzyme) Glucose 8%, yeast extract 1%, manganese sulfate 10p
pm, 18 L of a medium with a composition of 2% calcium carbonate was placed in a 30 L jar fermenter, heat sterilized, and then 500 ml of a culture of Leuconostoc dextranicum IFO27310 previously cultured in the same medium as above.
l was inoculated. The cells were cultured for 18 hours at 30°C, 200 rpm, and gas phase aeration.

【0036】得られた培養液を遠心分離に供し集菌した
後、生理的食塩水にて洗浄した。得られた湿菌体200
gに10mMリン酸緩衝液(pH7.2)(0.02%
の2−メルカプトエタノールを含む)200mlを加え
、菌体を超音波破砕した。この破砕液を10000G、
10分間遠心分離し、上澄液180mlを得た。
The obtained culture solution was subjected to centrifugation to collect bacteria, and then washed with physiological saline. Obtained wet bacterial cells 200
10mM phosphate buffer (pH 7.2) (0.02%
(containing 2-mercaptoethanol) was added thereto, and the bacterial cells were disrupted by ultrasonication. 10000G of this crushing liquid,
Centrifugation was performed for 10 minutes to obtain 180 ml of supernatant.

【0037】この粗抽出液を上記と同じ緩衝液で平衡化
したDEAE−セルロースのカラム(10×20cm)
に負荷した。このカラムを前記と同じ緩衝液1Lで洗浄
した後、KCl濃度を順次上げるステップワイズ法で目
的酵素を溶出したところ、0.2M濃度のところで、溶
出した。
[0037] This crude extract was equilibrated with the same buffer as above on a DEAE-cellulose column (10 x 20 cm).
was loaded. After washing this column with 1 L of the same buffer solution as above, the target enzyme was eluted using a stepwise method in which the KCl concentration was gradually increased, and it was eluted at a concentration of 0.2M.

【0038】この活性画分を限外濾過法で濃縮した後、
前記と同様にして、DEAE−トヨパール650Mのカ
ラム(4×30cm)に負荷し、同様な方法で溶出した
ところ、KCl濃度0.15Mのところで目的酵素が溶
出した。
After concentrating this active fraction by ultrafiltration,
In the same manner as above, it was loaded onto a DEAE-Toyopearl 650M column (4 x 30 cm) and eluted in the same manner, and the target enzyme was eluted at a KCl concentration of 0.15M.

【0039】この活性画分を前記と同様に濃縮した後、
0.2MのKClを含む前記と同様の緩衝液で平衡化し
たセルロファインGCL−2000のカラム(2×10
0cm)を用いてゲル濾過を行なった。活性画分を前記
と同様に濃縮し、常法に従ってポリアクリルアミドゲル
電気泳動法により、純度を調べたところ、単一のバンド
として検出され、酵素標品の均一性が確認された。
After concentrating this active fraction in the same manner as above,
A Cellulofine GCL-2000 column (2 x 10
Gel filtration was performed using 0 cm). The active fraction was concentrated in the same manner as above, and the purity was examined by polyacrylamide gel electrophoresis according to a conventional method. A single band was detected, confirming the homogeneity of the enzyme preparation.

【0040】精製過程を表1に纏めて示す。The purification process is summarized in Table 1.

【0041】[0041]

【表1】 実施例2(基質特異性) 標準活性測定法に準拠し、実施例1で得られた酵素標品
を用い、表2に記載の各種の基質について反応速度を調
べた。2−オキソ−4−フェニル酪酸に対する活性を1
00とし、得られた結果を、表2に相対活性として示す
[Table 1] Example 2 (Substrate specificity) Using the enzyme preparation obtained in Example 1, reaction rates were investigated for the various substrates listed in Table 2 according to a standard activity measurement method. The activity against 2-oxo-4-phenylbutyric acid was 1
00, and the obtained results are shown in Table 2 as relative activity.

【0042】なお、この反応において、NADPHをN
ADHで代替できない。
[0042] In this reaction, NADPH is
It cannot be replaced by ADH.

【0043】[0043]

【表2】 実施例3(至適pH) 実施例1で得られた酵素標品の至適pHを次のようにし
て調べた。すなわち、標準活性測定法に準拠し、緩衝液
の種類及びpHを変化させて、酵素標品の活性を測定し
た。なお、pH調整に際して、pH5〜8の範囲では2
00mMリン酸緩衝液を用い、pH7〜9の範囲では2
00mMトリス−塩酸緩衝液を用いた。
[Table 2] Example 3 (Optimal pH) The optimal pH of the enzyme preparation obtained in Example 1 was investigated as follows. That is, the activity of the enzyme preparation was measured according to a standard activity measurement method while varying the type and pH of the buffer solution. In addition, when adjusting the pH, in the range of pH 5 to 8,
Using 00mM phosphate buffer, 2
00mM Tris-HCl buffer was used.

【0044】リン酸緩衝液(pH6.0)で測定した活
性を100とし、得られた結果を、図1に相対活性とし
て示す。
The activity measured in phosphate buffer (pH 6.0) was set as 100, and the results obtained are shown in FIG. 1 as relative activity.

【0045】図1より、リン酸緩衝液において、酵素標
品の至適pHは6付近である。
From FIG. 1, the optimal pH of the enzyme preparation in the phosphate buffer is around 6.

【0046】実施例4(pH安定性) 実施例1で得られた酵素標品のpH安定性を次のように
して調べた。すなわち、pHの異なる緩衝液2mlに酵
素標品0.5mlを添加し、20℃で20分間処理した
。なお、pH5〜7では200mMリン酸緩衝液、pH
7〜9では200mMトリス−塩酸緩衝液を用いた。 次いで、処理液0.1mlをサンプリングし、1Mリン
酸緩衝液(pH7.0)0.5mlを添加し、酵素を含
む液0.05mlを用い、標準活性測定法により、残存
活性を測定した。
Example 4 (pH Stability) The pH stability of the enzyme preparation obtained in Example 1 was investigated as follows. That is, 0.5 ml of the enzyme preparation was added to 2 ml of buffer solutions with different pH, and the mixture was treated at 20° C. for 20 minutes. In addition, at pH 5 to 7, 200mM phosphate buffer, pH
7 to 9, 200 mM Tris-HCl buffer was used. Next, 0.1 ml of the treated solution was sampled, 0.5 ml of 1M phosphate buffer (pH 7.0) was added, and residual activity was measured by a standard activity measurement method using 0.05 ml of the enzyme-containing solution.

【0047】リン酸緩衝液(pH6.0)で処理した場
合の残存活性を100とし、結果を、図2に相対活性と
して示す。
The residual activity when treated with phosphate buffer (pH 6.0) was set as 100, and the results are shown in FIG. 2 as relative activity.

【0048】図2より、酵素標品は、リン酸緩衝液にお
いてpH6〜7で安定である。
From FIG. 2, the enzyme preparation is stable at pH 6 to 7 in phosphate buffer.

【0049】実施例5(至適温度) 実施例1で得られた酵素標品の至適温度を、次のように
して調べた。すなわち、標準活性測定法に準拠して、反
応温度を変化させ、反応速度を測定した。そして、反応
温度45℃での反応速度を100とし、得られた結果を
図3に相対反応速度として示す。
Example 5 (Optimal Temperature) The optimal temperature of the enzyme preparation obtained in Example 1 was investigated as follows. That is, the reaction temperature was varied and the reaction rate was measured according to a standard activity measurement method. The reaction rate at a reaction temperature of 45° C. was set as 100, and the obtained results are shown in FIG. 3 as relative reaction rates.

【0050】図3より、酵素標品の至適温度は45℃付
近である。
From FIG. 3, the optimal temperature for the enzyme preparation is around 45°C.

【0051】実施例6(熱安定性) 実施例1で得られた酵素標品の熱安定性を、次のように
して調べた。すなわち、酵素標品に200mMリン酸緩
衝液(pH7.2)を添加し、pHを7.2に調整した
後、異なる温度条件下で20分間処理し、処理液の残存
活性を、標準活性測定法により測定した。そして、20
℃での活性を100とし、結果を図4に残存活性(%)
として示す。
Example 6 (Thermostability) The thermostability of the enzyme preparation obtained in Example 1 was investigated as follows. That is, after adding 200 mM phosphate buffer (pH 7.2) to the enzyme preparation and adjusting the pH to 7.2, it was treated for 20 minutes under different temperature conditions, and the residual activity of the treated solution was determined by standard activity measurement. It was measured by the method. And 20
The activity at °C is set as 100, and the results are shown in Figure 4 as residual activity (%).
Shown as

【0052】図4より、酵素標品は40℃以下では安定
である。
From FIG. 4, the enzyme preparation is stable at temperatures below 40°C.

【0053】実施例7(2−オキソ−4−フェニル酪酸
に対するKm値) 実施例1で得られた酵素標品を用い、2−オキソ−4−
フェニル酪酸の濃度を変化させ、標準活性測定法により
、活性を測定し、Km値を求めたところ、0.29mM
であった。
Example 7 (Km value for 2-oxo-4-phenylbutyric acid) Using the enzyme preparation obtained in Example 1, 2-oxo-4-
When the concentration of phenylbutyric acid was changed and the activity was measured using a standard activity measurement method, the Km value was determined to be 0.29mM.
Met.

【0054】実施例8(阻害剤) 実施例1で得られた酵素標品に対する各種の阻害剤の影
響を、次のようにして調べた。すなわち、標準活性法に
よる反応系に、表7に示す阻害剤を添加し、酵素と共に
30℃で5分間インキュベートした後、NADPHを添
加して反応を開始し、活性を測定した。そして、阻害剤
を添加しない場合の活性を100とし、得られた活性を
、表3に相対活性として示す。
Example 8 (Inhibitors) The effects of various inhibitors on the enzyme preparation obtained in Example 1 were investigated as follows. That is, the inhibitors shown in Table 7 were added to a reaction system based on the standard activity method, and after incubating with the enzyme at 30° C. for 5 minutes, NADPH was added to start the reaction, and the activity was measured. The activity when no inhibitor was added was set as 100, and the obtained activities are shown in Table 3 as relative activities.

【0055】[0055]

【表3】 表3より、酵素標品の活性は、塩化水銀およびパラクロ
ロ水銀安息香酸で阻害される。
[Table 3] From Table 3, the activity of the enzyme preparation is inhibited by mercuric chloride and parachloromercuric benzoic acid.

【0056】実施例9(分子量) 実施例1で得られた酵素標品の分子量を、HPLC法に
よるゲル濾過法により測定した。すなわち、アサヒパッ
ク(Asahipak)GS−520(0.75×60
cm)(旭化成(株)製)をカラムとして用い、常法に
より、HPLC法で分子量を求めたところ、46000
であった。
Example 9 (Molecular Weight) The molecular weight of the enzyme preparation obtained in Example 1 was measured by gel filtration using HPLC. That is, Asahipak GS-520 (0.75×60
cm) (manufactured by Asahi Kasei Co., Ltd.) as a column, the molecular weight was determined by HPLC method using a conventional method, and it was found to be 46,000.
Met.

【0057】実施例10((R)−2−ヒドロキシ−4
−フェニル酪酸の製造) 2−オキソ−4−フェニル酪酸100mgを、20ml
の水に溶解し、1NのNaOHにてpH6とした。この
溶液にNADPH500mgを添加し溶解した後、10
0mMリン酸緩衝液(pH6.0)20mlを添加した
。次いで、実施例1と同様にして得られた酵素の溶液5
ml(200U)を添加し、30℃で24時間反応した
Example 10 ((R)-2-hydroxy-4
-Production of phenylbutyric acid) 100mg of 2-oxo-4-phenylbutyric acid, 20ml
of water and adjusted to pH 6 with 1N NaOH. After adding 500 mg of NADPH to this solution and dissolving it,
20 ml of 0 mM phosphate buffer (pH 6.0) was added. Next, enzyme solution 5 obtained in the same manner as in Example 1
ml (200 U) was added and reacted at 30°C for 24 hours.

【0058】反応液を、1N硫酸にてpH2.5とし、
塩化ナトリウムを飽和になるまで溶解させ、反応生成物
を酢酸エチル50mlにて2回抽出した。有機層を合わ
せて、溶媒を留去し、粗結晶80mgを得た。この粗結
晶をトルエンで再結晶し、結晶68mg(収率68%)
を得た。
The reaction solution was adjusted to pH 2.5 with 1N sulfuric acid,
Sodium chloride was dissolved until saturated, and the reaction product was extracted twice with 50 ml of ethyl acetate. The organic layers were combined and the solvent was distilled off to obtain 80 mg of crude crystals. The crude crystals were recrystallized from toluene to produce 68 mg of crystals (yield: 68%).
I got it.

【0059】mp:113.5℃ [α]D =−8.5(c=1,エタノール)得られた
結晶を少量の水に溶解し、光学分割カラムを用いる高速
液体クロマトグラフィー(カラム:ダイセル化学工業(
株)製、キラルセルOB、溶媒:n−ヘキサン/2−プ
ロパノール=19:1)に供し、絶対配置及び光学純度
を測定したところ、生成物と(R)−2−ヒドロキシ−
4−フェニル酪酸とのリテンションタイムが完全に一致
し、生成物の光学純度も100%e.e.であった。
mp: 113.5°C [α]D = -8.5 (c = 1, ethanol) The obtained crystals were dissolved in a small amount of water and subjected to high performance liquid chromatography using an optical resolution column (column: Daicel Chemical industry (
Co., Ltd., Chiralcel OB, solvent: n-hexane/2-propanol = 19:1), and the absolute configuration and optical purity were measured, and it was found that the product and (R)-2-hydroxy-
The retention time completely matched that of 4-phenylbutyric acid, and the optical purity of the product was 100% e. e. Met.

【図面の簡単な説明】[Brief explanation of the drawing]

【図1】実施例3における酵素標品の至適pHを示すた
めのグラフである。
FIG. 1 is a graph showing the optimum pH of the enzyme preparation in Example 3.

【図2】実施例4における酵素標品の安定なpH範囲を
示すためのグラフである。
FIG. 2 is a graph showing the stable pH range of the enzyme preparation in Example 4.

【図3】実施例5における酵素標品の至適温度を示すた
めのグラフである。
FIG. 3 is a graph showing the optimum temperature of the enzyme preparation in Example 5.

【図4】実施例6における酵素標品の安定な温度範囲を
示すためのグラフである。
FIG. 4 is a graph showing the stable temperature range of the enzyme preparation in Example 6.

Claims (1)

【特許請求の範囲】 【請求項1】  下記(1) 〜(8) の理化学的性
質を有する新規酵素。 (1) 作用および基質特異性:還元型ニコチンアミド
・アデニン・ジヌクレオチド・リン酸の存在下、2−オ
キソ−4−フェニル酪酸を不斉還元し、(R)−2−ヒ
ドロキシ−4−フェニル酪酸を生成する (2) 至適pH:6.0付近(リン酸緩衝液)(3)
 安定pH範囲:6〜7(リン酸緩衝液)(4) 至適
温度:45℃付近(pH6.0)(5) 熱安定性:4
0℃以下で安定(pH7.2、処理時間20分) (6) 2−オキソ−4−フェニル酪酸に対するミハエ
リス定数Km値:0.29mM (7) 分子量:46000(ゲル濾過法)(8) 阻
害剤:塩化水銀およびパラクロロ水銀安息香酸【請求項
2】  還元型ニコチンアミド・アデニン・ジヌクレオ
チド・リン酸の存在下、アルデヒド類及びケトン類を還
元し、これらに対応する等モルのアルコールを生成する
請求項1記載の新規酵素。 【請求項3】  ロイコノストック(Leuconos
toc)属に属する微生物を培養し、該培養物から、請
求項1記載の酵素を採取する、新規酵素の製造方法。 【請求項4】  還元型ニコチンアミド・アデニン・ジ
ヌクレオチド・リン酸の存在下、請求項1記載の酵素を
、2−オキソ−4−フェニル酪酸に作用させて不斉還元
する、光学活性な(R)−2−ヒドロキシ−4−フェニ
ル酪酸の製造方法。
[Scope of Claims] [Claim 1] A novel enzyme having the following physical and chemical properties (1) to (8). (1) Action and substrate specificity: In the presence of reduced nicotinamide adenine dinucleotide phosphate, 2-oxo-4-phenylbutyric acid is asymmetrically reduced to produce (R)-2-hydroxy-4-phenyl Generates butyric acid (2) Optimum pH: around 6.0 (phosphate buffer) (3)
Stable pH range: 6-7 (phosphate buffer) (4) Optimum temperature: around 45°C (pH 6.0) (5) Thermal stability: 4
Stable below 0°C (pH 7.2, treatment time 20 minutes) (6) Michaelis constant Km value for 2-oxo-4-phenylbutyric acid: 0.29mM (7) Molecular weight: 46000 (gel filtration method) (8) Inhibition Agents: mercuric chloride and parachloromercuric benzoic acid [Claim 2] In the presence of reduced nicotinamide, adenine, dinucleotide, and phosphoric acid, aldehydes and ketones are reduced to produce equimolar alcohols corresponding to these. The novel enzyme according to claim 1. [Claim 3] Leuconostoc
A method for producing a novel enzyme, which comprises culturing a microorganism belonging to the genus Toc and collecting the enzyme according to claim 1 from the culture. 4. An optically active compound (2-oxo-4-phenylbutyric acid) which causes the enzyme according to claim 1 to act on 2-oxo-4-phenylbutyric acid for asymmetric reduction in the presence of reduced nicotinamide adenine dinucleotide phosphate. R) Method for producing -2-hydroxy-4-phenylbutyric acid.
JP3131964A 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid Expired - Fee Related JP2750017B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3131964A JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3131964A JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Publications (2)

Publication Number Publication Date
JPH04335886A true JPH04335886A (en) 1992-11-24
JP2750017B2 JP2750017B2 (en) 1998-05-13

Family

ID=15070341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3131964A Expired - Fee Related JP2750017B2 (en) 1991-05-07 1991-05-07 Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid

Country Status (1)

Country Link
JP (1) JP2750017B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059237A1 (en) * 2004-08-30 2006-06-08 Lunamed, Inc. 4-phenylbutyric acid controlled-release formulations for therapeutic use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059237A1 (en) * 2004-08-30 2006-06-08 Lunamed, Inc. 4-phenylbutyric acid controlled-release formulations for therapeutic use

Also Published As

Publication number Publication date
JP2750017B2 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
US4352885A (en) Preparation of a novel NADP linked alcohol-aldehyde/ketone oxidoreductase from thermophilic anaerobic bacteria for analytical and commercial use
US5888804A (en) Processes for production of optically active quinuclidinol
JP3858505B2 (en) Method for producing R-3-quinuclidinol
US5783428A (en) Method of producing fumaric acid
JPS62289A (en) Enzymatic production of l-alpha-amino acid from alpha-ketoic acid
WO2007026860A1 (en) METHOD FOR PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYCARBOXYLIC ACID
US4622301A (en) 2-Oxocarboxylic acid reductase and its preparation
JPH04335886A (en) New enzyme, production thereof and production of optically active (r)-2-hydroxy-4-phenylbutyric acid
JPS58201985A (en) Production of glucose dehydrogenase
JP2801694B2 (en) New enzyme
EP0365029B1 (en) Method of systhesizing optically active beta-halolactic acid or glycidic acid
JP2005117905A (en) Method for producing optically active 1-benzyl-3-pyrrolidinol
JPH0328188B2 (en)
JPH01317387A (en) Novel d-amidase and production of d-alpha-alanine and/or l-alpha-alanineamide using same
JP4160417B2 (en) Secondary alcohol dehydrogenase and production method thereof
JP3055711B2 (en) Method for producing optically active (S) -3-phenyl-1,3-propanediol
US20010036660A1 (en) Method of producing optically active N-methylamino acids
JP3917723B2 (en) Lactone hydrolase and process for producing the same
JPH04341195A (en) Production of optically active mandelic acid
Kit et al. Patents and literature
JP3843692B2 (en) Process for the production of optically active endo-norborneol
JPH1075797A (en) Production of (r)-2-hydroxy-4-phenyl-3-butenoic acid by enzymatic method
JPS5817590B2 (en) Method for producing L-malic acid dehydrogenated oxygen
US20020068337A1 (en) Method for enhancing activity to regenerate electron acceptor for oxidoreductase in microorganism capable of producing said oxidoreductase, and use of microorganism prepared by said method
JPH05260964A (en) New enzyme, its production and production of d-lactic acid with the enzyme

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080220

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090220

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100220

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100220

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110220

Year of fee payment: 13

LAPS Cancellation because of no payment of annual fees